Summary statement: utility of molecular marker testing in thyroid cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21134567.
- Also identified by DOI 10.1016/j.surg.2010.09.023 and PMC identifier 3052981.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The use of molecular markers for thyroid cancer diagnosis, prognosis, and surveillance have been an exciting area of study and change. Recent investigative focus on promising new markers will very likely lead to improvements in the diagnostic utility of fine needle aspiration biopsy (FNAB) in predicting malignancy, as well as provide more accurate prognostic information pre- and postoperatively. The 2010 Annual Meeting of the American Association for Endocrine Surgeons featured a symposium dedicated to molecular marker testing in thyroid cancer and its potential clinical applicability.
Medical subject headings
- Biopsy, Fine-Needle
- Genetic Markers
- Oligonucleotide Array Sequence Analysis
- Thyroid Neoplasms